# LCNB Corp: financial statements, quarterly

LCNB · Nasdaq · CIK 1074902 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lcnb.md) · [Financials](/companies/lcnb/financials.md) · [Filings](/companies/lcnb/filings.md) · [Insiders](/companies/lcnb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lcnb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [6.1](/filings/0001074902-23-000100.md) | [8.7 d](/filings/0001074902-24-000123.md) | [10.9](/filings/0001074902-24-000079.md) | [11.7](/filings/0001074902-24-000106.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.9](/filings/0001437749-24-033634.md) | [(0.2) d](/filings/0001437749-26-007758.md) | [0.3](/filings/0001437749-25-015116.md) | [0.0](/filings/0001437749-25-025068.md) | [0.8](/filings/0001437749-25-033333.md) | [1.3 d](/filings/0001437749-26-007758.md) | [0.9](/filings/0001437749-26-015192.md) | [1.3](/filings/0001437749-26-025919.md) | [1.5](/filings/0001437749-25-033333.md) | [1.3 d](/filings/0001437749-26-007758.md) | [0.9](/filings/0001437749-26-015192.md) | [1.7](/filings/0001437749-26-025919.md) |
| Net income | $m | [4.1](/filings/0001437749-24-033634.md) | [(0.3) d](/filings/0001437749-26-007758.md) | [1.9](/filings/0001437749-25-015116.md) | [0.9](/filings/0001437749-25-025068.md) | [4.5](/filings/0001437749-25-033333.md) | [6.1 d](/filings/0001437749-26-007758.md) | [4.6](/filings/0001437749-26-015192.md) | [5.9](/filings/0001437749-26-025919.md) | [6.9](/filings/0001437749-25-033333.md) | [5.7 d](/filings/0001437749-26-007758.md) | [4.4](/filings/0001437749-26-015192.md) | [7.5](/filings/0001437749-26-025919.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001437749-24-033634.md) | not reported | [0.15](/filings/0001437749-25-015116.md) | [0.07](/filings/0001437749-25-025068.md) | [0.31](/filings/0001437749-25-033333.md) | not reported | [0.33](/filings/0001437749-26-015192.md) | [0.41](/filings/0001437749-26-025919.md) | [0.49](/filings/0001437749-25-033333.md) | not reported | [0.31](/filings/0001437749-26-015192.md) | [0.53](/filings/0001437749-26-025919.md) |
| Basic EPS | $ per share | [0.37](/filings/0001437749-24-033634.md) | not reported | [0.15](/filings/0001437749-25-015116.md) | [0.07](/filings/0001437749-25-025068.md) | [0.31](/filings/0001437749-25-033333.md) | not reported | [0.33](/filings/0001437749-26-015192.md) | [0.41](/filings/0001437749-26-025919.md) | [0.49](/filings/0001437749-25-033333.md) | not reported | [0.31](/filings/0001437749-26-015192.md) | [0.53](/filings/0001437749-26-025919.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [43.4](/filings/0001074902-23-000100.md) | [39.7](/filings/0001437749-25-007283.md) | [33.0](/filings/0001074902-24-000079.md) | [34.9](/filings/0001074902-24-000106.md) | [39.4](/filings/0001437749-24-033634.md) | [35.7](/filings/0001437749-26-007758.md) | [37.7](/filings/0001437749-25-015116.md) | [49.8](/filings/0001437749-25-025068.md) | [35.9](/filings/0001437749-25-033333.md) | [21.6](/filings/0001437749-26-025919.md) | [29.2](/filings/0001437749-26-015192.md) | [24.9](/filings/0001437749-26-025919.md) |
| Total assets | $m | [1,982](/filings/0001074902-23-000100.md) | [2,292](/filings/0001437749-25-007283.md) | [2,283](/filings/0001074902-24-000079.md) | [2,371](/filings/0001074902-24-000106.md) | [2,347](/filings/0001437749-24-033634.md) | [2,307](/filings/0001437749-26-007758.md) | [2,303](/filings/0001437749-25-015116.md) | [2,308](/filings/0001437749-25-025068.md) | [2,244](/filings/0001437749-25-033333.md) | [2,241](/filings/0001437749-26-025919.md) | [2,238](/filings/0001437749-26-015192.md) | [2,224](/filings/0001437749-26-025919.md) |
| Total liabilities | $m | [1,780](/filings/0001074902-23-000100.md) | [2,056](/filings/0001437749-25-007283.md) | [2,049](/filings/0001074902-24-000079.md) | [2,126](/filings/0001074902-24-000106.md) | [2,094](/filings/0001437749-24-033634.md) | [2,054](/filings/0001437749-26-007758.md) | [2,044](/filings/0001437749-25-015116.md) | [2,044](/filings/0001437749-25-025068.md) | [1,974](/filings/0001437749-25-033333.md) | [1,967](/filings/0001437749-26-025919.md) | [1,962](/filings/0001437749-26-015192.md) | [1,943](/filings/0001437749-26-025919.md) |
| Long-term debt | $m | [113](/filings/0001074902-23-000100.md) | [113](/filings/0001437749-25-007283.md) | [163](/filings/0001074902-24-000079.md) | [162](/filings/0001074902-24-000106.md) | [156](/filings/0001437749-24-033634.md) | [155](/filings/0001437749-26-007758.md) | [105](/filings/0001437749-25-015116.md) | [105](/filings/0001437749-25-025068.md) | [105](/filings/0001437749-25-033333.md) | [104](/filings/0001437749-26-025919.md) | [104](/filings/0001437749-26-015192.md) | [104](/filings/0001437749-26-025919.md) |
| Short-term borrowings | $m | [30.0](/filings/0001074902-23-000100.md) | [97.4](/filings/0001437749-25-007283.md) | [10.0](/filings/0001074902-24-000079.md) | [0.0](/filings/0001074902-24-000106.md) | [0.0](/filings/0001437749-24-033634.md) | [0.0](/filings/0001437749-26-007758.md) | [0.0](/filings/0001437749-25-015116.md) | [0.0](/filings/0001437749-25-025068.md) | [0.0](/filings/0001437749-25-033333.md) | [0.0](/filings/0001437749-26-025919.md) | [0.0](/filings/0001437749-26-015192.md) | [0.0](/filings/0001437749-26-025919.md) |
| Shareholders' equity | $m | [201](/filings/0001437749-24-033634.md) | [235](/filings/0001437749-26-007758.md) | [234](/filings/0001437749-25-025068.md) | [245](/filings/0001437749-25-033333.md) | [253](/filings/0001437749-25-033333.md) | [253](/filings/0001437749-26-025919.md) | [259](/filings/0001437749-26-025919.md) | [263](/filings/0001437749-26-025919.md) | [270](/filings/0001437749-25-033333.md) | [274](/filings/0001437749-26-025919.md) | [276](/filings/0001437749-26-025919.md) | [281](/filings/0001437749-26-025919.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5.2 d](/filings/0001437749-24-033634.md) | [11.1 d](/filings/0001437749-26-007758.md) | [(11.9)](/filings/0001437749-25-015116.md) | [54.9 d](/filings/0001437749-25-025068.md) | [11.9 d](/filings/0001437749-25-033333.md) | [38.4 d](/filings/0001437749-26-007758.md) | [2.2](/filings/0001437749-26-015192.md) | [5.5 d](/filings/0001437749-26-025919.md) | [14.0 d](/filings/0001437749-25-033333.md) | [12.7 d](/filings/0001437749-26-007758.md) | [3.1](/filings/0001437749-26-015192.md) | [8.8 d](/filings/0001437749-26-025919.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001437749-24-033634.md) | [0.9 d](/filings/0001437749-26-007758.md) | [0.9](/filings/0001437749-25-015116.md) | [1.1 d](/filings/0001437749-25-025068.md) | [1.4 d](/filings/0001437749-25-033333.md) | [0.4 d](/filings/0001437749-26-007758.md) | [0.1](/filings/0001437749-26-015192.md) | [0.2 d](/filings/0001437749-26-025919.md) | [0.3 d](/filings/0001437749-25-033333.md) | [0.3 d](/filings/0001437749-26-007758.md) | [0.3](/filings/0001437749-26-015192.md) | [1.4 d](/filings/0001437749-26-025919.md) |
| Dividends paid | $m | [2.3 d](/filings/0001437749-24-033634.md) | [2.9 d](/filings/0001437749-26-007758.md) | [2.9](/filings/0001437749-25-015116.md) | [3.1 d](/filings/0001437749-25-025068.md) | [3.1 d](/filings/0001437749-25-033333.md) | [3.2 d](/filings/0001437749-26-007758.md) | [3.1](/filings/0001437749-26-015192.md) | [3.1 d](/filings/0001437749-26-025919.md) | [3.2 d](/filings/0001437749-25-033333.md) | [3.1 d](/filings/0001437749-26-007758.md) | [3.1](/filings/0001437749-26-015192.md) | [3.1 d](/filings/0001437749-26-025919.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-033634.md) | [0.0 d](/filings/0001074902-24-000123.md) | [0.0](/filings/0001074902-24-000079.md) | [0.0 d](/filings/0001074902-24-000106.md) | [0.0 d](/filings/0001437749-24-033634.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.3](/filings/0001074902-23-000100.md) | [11.2](/filings/0001074902-24-000079.md) | [11.1](/filings/0001074902-24-000106.md) | [11.0](/filings/0001437749-24-033634.md) | [13.1](/filings/0001437749-25-015116.md) | [13.9](/filings/0001437749-25-025068.md) | [14.0](/filings/0001437749-25-033333.md) | [14.1](/filings/0001437749-26-015192.md) | [14.1](/filings/0001437749-26-025919.md) | [14.1](/filings/0001437749-25-033333.md) | [14.1](/filings/0001437749-26-015192.md) | [14.2](/filings/0001437749-26-025919.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,254,988 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025919.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.